PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation
eLife · 05.02.2024 · 13
DOI: 10.7554/elife.89740 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 05.02.2024. Verfasst von Changlin Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical Univer…. Hauptthemen laut MEDLINE: Extracellular Traps, Acute Kidney Injury, Aristolochic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Anhui Province, Anhui Medical University.
Abstract (Originalsprache)
Aristolochic acid nephropathy (AAN) is a progressive kidney disease caused by herbal medicines. Proline–serine–threonine phosphatase-interacting protein 2 (PSTPIP2) and neutrophil extracellular traps (NETs) play important roles in kidney injury and immune defense, respectively, but the mechanism underlying AAN regulation by PSTPIP2 and NETs remains unclear. We found that renal tubular epithelial cell (RTEC) apoptosis, neutrophil infiltration, inflammatory factor, and NET production were increased in a mouse model of AAN, while PSTPIP2 expression was low. Conditional knock-in of Pstpip2 in mouse kidneys inhibited cell apoptosis, reduced neutrophil infiltration, suppressed the production of inflammatory factors and NETs, and ameliorated renal dysfunction. Conversely, downregulation of Pstpip2 expression promoted kidney injury. In vivo, the use of Ly6G-neutralizing antibody to remove neutrophils and peptidyl arginine deiminase 4 (PAD4) inhibitors to prevent NET formation reduced apoptosis, alleviating kidney injury. In vitro, damaged RTECs released interleukin-19 (IL-19) via the PSTPIP2/nuclear factor (NF)-κB pathway and induced NET formation via the IL-20Rβ receptor. Concurrently, NETs promoted apoptosis of damaged RTECs. PSTPIP2 affected NET formation by regulating IL-19 expression via inhibition of NF-κB pathway activation in RTECs, inhibiting RTEC apoptosis, and reducing kidney damage. Our findings indicated that neutrophils and NETs play a key role in AAN and therapeutic targeting of PSTPIP2/NF-κB/IL-19/IL-20Rβ might extend novel strategies to minimize Aristolochic acid I-mediated acute kidney injury and apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.
ORCID-Profile: Taotao Ma
Förderung
- Department of Science and Technology of Anhui Province
- Anhui Medical University
Zitieren
APA
Du, C., Xu, C., Jia, P., Cai, N., Zhang, Z., Meng, W., Chen, L., Zhou, Z., Wang, Q., Feng, R., Li, J., Meng, X., Huang, C., & Ma, T. (2024). PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation. eLife, 13. https://doi.org/10.7554/elife.89740
Vancouver
Du C, Xu C, Jia P, Cai N, Zhang Z, Meng W, et al. PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation. eLife. 2024;13. doi:10.7554/elife.89740
BibTeX
@article{Du2024,
author = {Du, Changlin and Xu, Chuanting and Jia, Pengcheng and Cai, Na and Zhang, Zhenming and Meng, Wenna and Chen, Lu and Zhou, Zhongnan and Wang, Qi and Feng, Rui and Li, Jun and Meng, Xiaoming and Huang, Cheng and Ma, Taotao},
title = {PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation},
journal = {eLife},
year = {2024},
volume = {13},
doi = {10.7554/elife.89740}
}
EUVIMED